Development and validation of a questionnaire to measure the congenital heart disease of children’s family stressor
Frontiers in Public Health · 2024
DOI: 10.3389/fpubh.2024.1365089 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Frontiers in Public Health, 2024. Verfasst von Yi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, China. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Stress, Psychological, Psychometrics. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Families of children with congenital heart disease (CHD) face tremendous stressors in the process of coping with the disease, which threatens the health of families of children with CHD. Studies have shown that nursing interventions focusing on family stress management can improve parents’ ability to cope with illness and promote family health. At present, there is no measuring tool for family stressors of CHD.
Methods
The items of the scale were generated through qualitative interviews and a literature review. Initial items were evaluated by seven experts to determine content validity. Factor analysis and reliability testing were conducted with a convenience sample of 670 family members. The criterion-related validity of the scale was calculated using scores on the Self-Rating Anxiety Scale (SAS).
Results
The CHD Children’s Family Stressor Scale consisted of six dimensions and 41 items. In the exploratory factor analysis, the cumulative explained variance of the six factors was 61.085%. In the confirmatory factor analysis, the six factors in the EFA were well validated, indicating that the model fits well. The correlation coefficient between CHD Children’s Family Stressor Scale and SAS was r = 0.504 ( p < 0.001), which indicated that the criterion-related validity of the scale was good. In the reliability test, Cronbach’s α coefficients of six sub-scales were 0.774–0.940, and the scale-level Cronbach’s α coefficient value was 0.945.
Conclusion
The study indicates that the CHD Children’s Family Stressor Scale is valid and reliable, and it is recommended for use in clinical practice to assess CHD children’s family stressors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, China.
- Department of Clinical Psychology, Yunnan Provincial Hospital of Infectious Disease, Kunming, China.
- Cardiology Department, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
- Psychiatric Department, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
- ICU in Geriatric Department, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
- Urology Department, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Zhou, H., Bai, Y., Chen, Z., Wang, Y., Hu, Q., Yang, M., Wei, W., Ding, L., & Ma, F. (2024). Development and validation of a questionnaire to measure the congenital heart disease of children’s family stressor. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2024.1365089
Vancouver
Zhang Y, Zhou H, Bai Y, Chen Z, Wang Y, Hu Q, et al. Development and validation of a questionnaire to measure the congenital heart disease of children’s family stressor. Frontiers in Public Health. 2024. doi:10.3389/fpubh.2024.1365089
BibTeX
@article{Zhang2024,
author = {Zhang, Yi and Zhou, Hang and Bai, Yangjuan and Chen, Zhisong and Wang, Yanjiao and Hu, Qiulan and Yang, Mingfang and Wei, Wei and Ding, Lan and Ma, Fang},
title = {Development and validation of a questionnaire to measure the congenital heart disease of children’s family stressor},
journal = {Frontiers in Public Health},
year = {2024},
doi = {10.3389/fpubh.2024.1365089}
}
EUVIMED